Glaxo, US partnering to develop new antibiotics

Seattle Times: LONDON — GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Read article